Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 12, Issue 9, Pages 1035-1048
Publisher
Future Medicine Ltd
Online
2018-07-25
DOI
10.2217/bmm-2018-0157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA1/2 testing: therapeutic implications for breast cancer management
- (2018) Nadine M. Tung et al. BRITISH JOURNAL OF CANCER
- Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer
- (2018) Z.F. Jiang et al. LIFE SCIENCES
- Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
- (2018) Martina Bonechi et al. Oncotarget
- The Half-Life of Serum Thymidine Kinase 1 Concentration Is an Important Tool for Monitoring Surgical Response in Patients with Lung Cancer: A Meta-Analysis
- (2017) Xudan Lou et al. Genetic Testing and Molecular Biomarkers
- Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia
- (2017) Evita Weagel et al. OncoTargets and Therapy
- Preclinical Applications of 3'-Deoxy-3'-[18F] Fluoro-thymidine in Oncology - A Systematic Review
- (2017) Sonja Schelhaas et al. Theranostics
- Dual addressing of thymidine synthesis pathways for effective targeting of proliferating melanoma
- (2017) Tara Miran et al. Cancer Medicine
- Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people
- (2016) Yu Wang et al. Cancer Biomarkers
- A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
- (2016) J. Kiran Kumar et al. TUMOR BIOLOGY
- Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging
- (2016) Xiao Chen et al. Oncotarget
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology
- (2013) Eliot T. McKinley et al. PLoS One
- Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients
- (2012) Benjamin Nisman et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma
- (2012) Vít Procházka et al. LEUKEMIA & LYMPHOMA
- Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
- (2012) Melissa M. Alegre et al. Journal of Oncology
- Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
- (2011) YONGPING LIU et al. Experimental and Therapeutic Medicine
- Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia
- (2010) C. F. R. Källander et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings
- (2010) Yan Chen et al. International Journal of Clinical Oncology
- Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage
- (2010) Yen-Ling Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients
- (2010) Zhu-Lin Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Enzymatic Regulation of Cytosolic Thymidine Kinase 1 and Mitochondrial Thymidine Kinase 2: A Mini Review
- (2010) B. Munch-Petersen NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays
- (2009) Fabio Gasparri et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors
- (2009) Wei Xu et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Imaging of Cell Proliferation: Status and Prospects
- (2008) J. R. Bading et al. JOURNAL OF NUCLEAR MEDICINE
- Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors
- (2008) R. F. Barth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started